• Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Tyr (c.94G>T); ClinVar=VCV000017581; Zygosity=Unspecified (PubMed=25645078).
  
• Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Homozygous (PubMed=25645078).
  
• Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu353Gly (c.1058A>G) (p.Glu156Gly, c.467A>G); ClinVar=VCV000237638; Zygosity=Heterozygous (PubMed=25645078).
  

PubMed=20689758; DOI=10.1593/neo.10414; PMCID=PMC2915408
William Douglas Tap, Ke-Wei Gong, Judy Dering, Yiou Tseng, Charles Ginther, Giovanni Pauletti, John A. Glaspy, Richard Essner, Gideon Bollag, Peter Hirth, Chao Zhang, Dennis Joseph Slamon;
Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.
Neoplasia 12:637-649(2010)

PubMed=22515704; DOI=10.1186/1476-4598-11-22; PMCID=PMC3444881
Erika Maria von Euw, Mohammad Atefi, Narsis Attar, Connie Chu, Sybil Zachariah, Barry L. Burgess, Stephen Mok, Charles Ng, Deborah J.L. Wong, Bartosz Chmielowski, David I. Lichter ...Show all 15 authors... , Richard C. Koya, Tara A. McCannel, Elena Izmailova, Antoni Ribas; Show fewer authors
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.
Mol. Cancer 11:22.1-22.9(2012)

PubMed=25645078; DOI=10.1186/s12943-015-0293-5; PMCID=PMC4320814
Mohammad Atefi, Bjoern Titz, Earl Avramis, Charles Ng, Deborah J.L. Wong, Amanda Lassen, Michael Cerniglia, Helena Escuin-Ordinas, David Foulad, Begonya Comin-Anduix, Thomas G. Graeber, Antoni Ribas;
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.
Mol. Cancer 14:27.1-27.12(2015)